Robert M. Williams Jr. - 20 Aug 2026 Form 4 Insider Report for Aveanna Healthcare Holdings, Inc. (AVAH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Aug 2026, 18:25:53 UTC
Prior SEC filing
02 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Zatlukal, Attorney-in-Fact

Key filing fact

Robert M. Williams Jr. filed Form 4 for Aveanna Healthcare Holdings, Inc. (AVAH) on 24 Aug 2026.

Key facts

  • This page summarizes Robert M. Williams Jr.'s Form 4 filing for Aveanna Healthcare Holdings, Inc. (AVAH).
  • 6 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Aug 2026, 18:25.

Change

  • Previous filing in this sequence was filed on 02 Jul 2026.
  • Current net transaction value: -$192,625,023.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001239610 Primary reporting owner

WILLIAMS ROBERT M JR

Relationship
10%+ Owner
Address
C/O J.H. WHITNEY CAPITAL PARTNERS, LLC, 212 ELM STREET, NEW CANAAN
Signature
/s/ David Zatlukal, Attorney-in-Fact
Signature date
24 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVAH transaction

Common Stock, $0.01 par value

Sale

Transaction value
$116,289,438
Shares
-10,112,125
Change %
-100%
Price
$11.50
Shares after
0
Date
20 Aug 2026
Ownership
By J.H. Whitney VII, L.P.
Footnotes
F1, F5
AVAH transaction

Common Stock, $0.01 par value

Sale

Transaction value
$11,016,057
Shares
-957,918
Change %
-6.2%
Price
$11.50
Shares after
14,565,892
Date
20 Aug 2026
Ownership
By PSA Healthcare Investment Holding LLC
Footnotes
F1, F6
AVAH transaction

Common Stock, $0.01 par value

Sale

Transaction value
$20,858,642
Shares
-1,813,795
Change %
-100%
Price
$11.50
Shares after
0
Date
20 Aug 2026
Ownership
By JHW Iliad Holdings, LLC
Footnotes
F2, F7
AVAH transaction

Common Stock, $0.01 par value

Sale

Transaction value
$16,399,391
Shares
-1,426,034
Change %
-100%
Price
$11.50
Shares after
0
Date
20 Aug 2026
Ownership
By PSA Iliad Holdings LLC
Footnotes
F1, F8
AVAH transaction

Common Stock, $0.01 par value

Sale

Transaction value
$2,186,495
Shares
-190,130
Change %
-100%
Price
$11.50
Shares after
0
Date
20 Aug 2026
Ownership
By JHW Iliad Holdings II, LLC
Footnotes
F2, F3, F9
AVAH transaction

Common Stock, $0.01 par value

Sale

Transaction value
$25,875,000
Shares
-2,250,000
Change %
-15%
Price
$11.50
Shares after
12,315,892
Date
21 Aug 2026
Ownership
By PSA Healthcare Investment Holding LLC
Footnotes
F1, F10
AVAH holding

Common Stock, $0.01 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
0
Date
20 Aug 2026
Ownership
Direct
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Robert M. Williams Jr. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 10 footnotes

Footnote F1

J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Footnote F2

Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Footnote F3

J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Footnote F4

Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Footnote F5

On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering.

Footnote F6

On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering.

Footnote F7

On August 20, 2026, JHW Iliad Holdings, LLC sold 1,813,795 Shares pursuant to an underwritten secondary offering.

Footnote F8

On August 20, 2026, JHW Iliad Holdings II, LLC sold 190,130 Shares pursuant to an underwritten secondary offering.

Footnote F9

On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering.

Footnote F10

On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .